The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hall Ashley since 2023.
This trader's CIK number is 1801842.
At the time of last reporting, Hall Ashley was the Chief Development Officer of Reneo Pharmaceuticals, Inc.. (stock ticker symbol RPHM).
Also see all insider trading activities at Reneo Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | RPHM | 0 | $0 | 15,625 | $98,062 | 15,625 | $28,125 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-28 | RPHM | Sale | 15,625 | 6.28 | 98,062 |
| 2023-08-28 | RPHM | Option Ex | 15,625 | 1.80 | 28,125 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hall Ashley (Chief Development Officer of Reneo Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.